What is PDRN serum, and does it actually work on skin?

What is PDRN serum, and why is it made from salmon?

PDRN serum is a topical product whose active ingredient is polydeoxyribonucleotide, a mixture of DNA fragments, usually from salmon. The buzz comes mostly from injection research, not from serums. Our PDRN topic page tracks the wider category.

PDRN is purified from the sperm DNA of salmon trout or chum salmon. One pharmacology review gives its molecular weight as 50 to 1,500 kDa and describes a registered drug with wound-healing uses.

Salmon is about purity. Sperm cells yield DNA with very little leftover protein, peptide or lipid compared with other tissue. The same review says high-temperature extraction produces a product over 95% pure with inactivated proteins.

That purity claim describes a pharmaceutical-grade product. It does not prove every cosmetic 'salmon DNA' ingredient is equally clean.

On a label, look for 'sodium DNA' or 'hydrolyzed DNA', common ingredient names. Alternatives exist but are early: a bacteria-derived PDRN with smaller fragments (under 100 base pairs versus 200 to 800 for salmon) has only been studied in vitro, and its better-absorption claim is a hypothesis.

One more distinction matters. Polynucleotide (PN) is a longer-chain, gel-like relative of PDRN, and many trials labeled 'PDRN' are really PN trials. Keep that in mind when a brand cites 'clinical studies'.

How does PDRN work?

The proposed biology is plausible, but it comes mostly from cells and animals. A narrative review describes two routes.

• Adenosine A2A receptor activation, which lowers inflammatory signals (TNF-α, IL-2, IL-1β) and raises VEGF, a driver of new blood vessels.
• The nucleotide 'salvage pathway', where PDRN supplies building blocks to dividing skin cells such as keratinocytes and fibroblasts.

The predicted result is less inflammation, more blood vessel growth and more fibroblast activity. That is a mechanism, not proof of visible results.

There is also a catch for shoppers. The receptor activity appears to depend on the DNA's origin, molecular weight and manufacturing process, so a differently made product may not behave the same way.

What does the injectable research show?

Injected PDRN and PN have small randomized trials behind them, with wound healing the most consistent win. A systematic review pooled 7 trials with 183 participants, covering rejuvenation, scar prevention and wound healing.

In the pooled trials, wrinkles, scar quality, healing and patient satisfaction generally improved, though the authors flag small samples and varied protocols. In one trial, re-epithelialization at day 7 was 46.75% with PDRN versus 19.25% in controls. In another, microneedling plus PDRN beat microneedling plus PRP for wrinkles at 6 weeks.

The authors flag small samples and varied protocols. A second systematic review calls polynucleotide evidence promising but notes limited consensus on best use, and it mixes PN and PDRN, so effects can't be pinned on PDRN alone.

A split-face trial of 27 people compared injected PN with non-crosslinked hyaluronic acid around the eyes. Overall improvement scores did not differ significantly, though PN scored higher on elasticity, hydration, roughness and pore volume. It tested PN, not PDRN, and it was small.

Our read: low to moderate evidence for injectables. Useful, not settled.

Can PDRN serum penetrate skin, and is it as effective as injections?

Penetration is the central weakness, and no study has compared a serum with injections. A 2025 paper states that topical use is limited because PDRN is large and negatively charged. Its fix, plasma treatment to shrink and neutralize the molecule, improved uptake in lab cells. That is a lab workaround, not a product.

Some background reasoning from us, not from the sources: the outer skin layer generally blocks molecules above roughly 500 daltons, and salmon PDRN fragments of 200 to 800 base pairs (roughly 130,000 to 520,000 daltons) are vastly larger.

The best topical data come from one paper on PDRN-850K, a medium-length fragment. Raman spectroscopy showed a PDRN-associated signal reaching living epidermal layers in a skin model. In UV-damaged ex vivo human skin, it increased epidermal thickness and collagen-related proteins.

Its randomized split-face trial ran 28 days: 0.1% PDRN-850K eye cream against 0.1% retinol. PDRN gave roughly twofold greater improvements in periocular wrinkles, dermal thickness, density and eye-bag measures, with good tolerability.

Treat that cautiously. The signal is indirect, the depth shown is epidermis rather than clearly dermis, and we could not see the sample size, funding or conflicts. It is one study of one proprietary fragment size, so it should not be generalized to every serum.

What are the real benefits of PDRN serum, and what is marketing?

Expect modest hydration at best, not injection-style regeneration; any barrier benefit is unproven. Most skin benefits are shown with injections: faster wound healing, modest wrinkle improvement, and in one small non-PDRN trial, higher elasticity and hydration subscores around the eyes (with no significant overall difference).

For topicals, a small study of peony-derived low-molecular-weight PDRN (10 people in the barrier-damage part) improved water loss after 2 weeks and periorbital elasticity after 4 weeks. It is plant-derived, not salmon, and small.

Also note that many serums don't disclose PDRN concentration or fragment size. The only topical concentration we found in research was 0.1%.

Is PDRN serum used for hair, and does that hold up?

Not on the evidence: we found no controlled trials of topical PDRN for hair. A 2026 commentary says the main PDRN hair data are one small randomized trial in female pattern hair loss from about a decade ago.

That trial reported better density and thickness, but it combined PRP with PDRN, and the commentary says the findings need validation before clinical use. Separately, an uncontrolled study of 28 men and women with androgenetic alopecia used a PN product, injected monthly four times. Dermatologists rated 60.7% as stabilized.

Any hair product should be measured against topical minoxidil, which is a commonly used benchmark in hair-loss studies. A PDRN scalp serum has nothing comparable.

Who should use PDRN serum?

People who want a hydrating product and accept modest, unproven results. It is not a treatment for irritated or post-procedure skin; anyone recovering from a procedure should follow their clinician's aftercare instructions. The eye cream was well tolerated, and the periocular injection trial reported no serious adverse events.

It is not a replacement for sunscreen or retinoids, which have far stronger evidence, or for in-office injectables. The eye cream trial compared against retinol, not injections, and lasted only 28 days.

• You have a fish or seafood allergy. We found no cross-reactivity data, so ask a clinician first.
• You are pregnant or breastfeeding. We found no data, so default to caution.
• You expect long-term proof. We found no long-term safety data.